Hologic | HOLX - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 9.21B 17M 2025-12
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Boston Scientific USD 4.04B 18M 2025-12
Bruker USD 900.9M 124.3M 2025-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Fuji Electric JPY 276.97B 6.08B 2025-12
Fujifilm JPY 767.39B 27.7B 2025-12
General Electric Aerospace USD 10.94B 7.87B 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Medtronic USD 7.28B 16M 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Philips EUR 4.38B 405M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Revvity USD 626.22M 25.62M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Siemens EUR 16.57B 2.29B 2025-12
Stryker USD 5.2B 505M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Waters USD 661.85M 1.67B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12